Consuelo Soldevila Pico, M.D.
Professor Of Medicine
Department:
MD-GASTROENTERLOGY-LIVER
Business Phone:
(352) 273-9400
Business Email:
soldevc@medicine.ufl.edu
About Consuelo Soldevila Pico
For the past 25 years, I have worked as a transplant hepatologist at the University of Florida Division of Gastroenterology, Hepatology & Nutrition. I treat patients with various liver conditions that include viral hepatitis, autoimmune disease, cirrhosis and liver transplant. I aim to provide complex care that restores patients’ health when they get seen in our Institution. The goal in our division is simple — Provide and guide patients through the best treatment available to restore their health.
I completed my internal medicine residency at the San Juan VA Medical Center in Puerto Rico. I did my gastroenterology fellowship at SUNY Downstate. I did a year of transplant hepatology at University of Pittsburgh. I did an additional year of combined training at Tulane University for advanced endoscopic training and hepatology with Dr Lok a world-renowned expert in HBV.
I enjoy learning about new techniques to bring to my practice and broaden my world view and knowledge when traveling.
Teaching Profile
Courses Taught
2018
MDC7200 Medicine Clerkship
2018
MDC7203 Senior Medicine Clerk
Board Certifications
-
GastroenterologyAmerican Board of Internal Medicine
-
Internal MedicineAmerican Board of Internal Medicine
-
Transplant HepatologyABIM
Clinical Profile
Specialties
- Transplant Hepatology
Research Profile
Open Researcher and Contributor ID (ORCID)
0009-0002-3008-8018
Publications
2018
Daclatasvir and sofosbuvir treatment of decompensated liver disease or post-liver transplant hepatitis C virus recurrence in patients with advanced liver disease/cirrhosis in a real-world cohort.
Hepatology communications.
2(4):354-363
[DOI] 10.1002/hep4.1156.
[PMID] 29619415.
2018
Histologic Characterization of Kratom Use-Associated Liver Injury.
Gastroenterology research.
11(1):79-82
[DOI] 10.14740/gr990e.
[PMID] 29511414.
2018
Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
16(4):558-566.e2
[DOI] 10.1016/j.cgh.2017.12.001.
[PMID] 29223443.
2013
Cc Genotype Donors for the Interleukin-28B Single Nucleotide Polymorphism Are Associated With Better Outcomes in Hepatitis C After Liver Transplant
Liver International.
33(1):72-78
[DOI] 10.1111/liv.12013.
[PMID] 23107586.
2013
Hepatic preservation injury: severity of hepatitis C recurrence and survival after liver transplantation.
Digestive diseases and sciences.
58(5):1403-9
[DOI] 10.1007/s10620-012-2521-9.
[PMID] 23306846.
2013
Histopathologic Resolution of Adult Liver Transplantation Adenovirus Hepatitis With Cidofovir and Intravenous Immunoglobulin: a Case Report
Transplantation proceedings.
45(1):293-296
[DOI] 10.1016/j.transproceed.2012.06.059.
[PMID] 23267812.
2013
Neutrophil-Lymphocyte Ratio Predicts Overall and Recurrence-Free Survival After Liver Transplantation for Hepatocellular Carcinoma
Hepatology Research.
43(7):757-764
[DOI] 10.1111/hepr.12019.
[PMID] 23193965.
2013
The Anti-Viral Effect of Sorafenib in Hepatitis C-Related Hepatocellular Carcinoma
Alimentary Pharmacology & Therapeutics.
37(1):91-97
[DOI] 10.1111/apt.12098.
[PMID] 23094860.
2013
Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma.
Oncology reports.
29(4):1259-67
[DOI] 10.3892/or.2013.2290.
[PMID] 23426976.
2012
Higher Than Expected Incidence of Chronic Myeloid Leukemia in Solid Organ Transplant Recipients.
Blood.
120
2012
Impact of transarterial therapy in hepatitis C-related hepatocellular carcinoma on long-term outcomes after liver transplantation.
American journal of clinical oncology.
35(4):345-50
[DOI] 10.1097/COC.0b013e31821631f6.
[PMID] 21552101.
2011
A Sustained Viral Response Dramatically Improves Survival in Patients With Hepatitis C Infection After Liver Transplant
.
54
2011
Antiviral Effect of Sorafenib in Hcv Related Hepatocellular Carcinoma
Higher Education Policy.
54
2011
Clinical Outcomes of Liver Transplantation for Hbv-Related Hepatocellular Carcinoma: Data From the Nih Hbv Olt Study
Clinical Transplantation.
25(2):E152-E162
[DOI] 10.1111/j.1399-0012.2010.01349.x.
[PMID] 21077950.
2011
Klatskin Tumor- Clinical Outcome and Prognostic Factors
Higher Education Policy.
54
2011
Low prevalence of HBV DNA in the liver allograft from anti-HBc-positive donors: a single-center experience.
Clinical transplantation.
25(1):164-70
[DOI] 10.1111/j.1399-0012.2010.01211.x.
[PMID] 20156222.
2011
Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid.
Alimentary pharmacology & therapeutics.
33(2):235-42
[DOI] 10.1111/j.1365-2036.2010.04512.x.
[PMID] 21083674.
2011
The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma.
Alimentary pharmacology & therapeutics.
34(2):205-13
[DOI] 10.1111/j.1365-2036.2011.04697.x.
[PMID] 21605146.
2010
Bacillus cereus necrotizing fasciitis in a patient with end-stage liver disease.
Surgical infections.
11(5):469-74
[DOI] 10.1089/sur.2009.026.
[PMID] 20649455.
2010
Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
10(8):1823-33
[DOI] 10.1111/j.1600-6143.2010.03046.x.
[PMID] 20346062.
2010
The Impact of Preservation Injury On Accelerated Hepatitis C Recurrence After Liver Transplantation
Higher Education Policy.
52
2010
The Impact of Transarterial Therapy in Recurrent Hepatocellular Carcinoma After Liver Transplant
Higher Education Policy.
52
2010
The use of cyclosporine for recurrent hepatitis C after liver transplant: a randomized pilot study.
Digestive diseases and sciences.
55(1):196-203
[DOI] 10.1007/s10620-009-0981-3.
[PMID] 19798576.
2009
Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial.
Hepatology (Baltimore, Md.).
50(6):1818-26
[DOI] 10.1002/hep.23239.
[PMID] 19824078.
2009
Fenofibrate Improves Liver Biochemistries in Primary Biliary Cirrhosis
Higher Education Policy.
50
2009
Hepatitis B Viral Dna Seldom Present in the Transplant Liver From Anti-Hbc-Positive Donors
Higher Education Policy.
50
2009
Liver transplantation outcomes among Caucasians, Asian Americans, and African Americans with hepatitis B.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
15(9):1010-20
[DOI] 10.1002/lt.21759.
[PMID] 19718627.
2009
The natural history of hepatitis C cirrhosis after liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
15(9):1063-71
[DOI] 10.1002/lt.21784.
[PMID] 19718647.
2009
Using An Immune Functional Assay To Differentiate Acute Cellular Rejection From Recurrent Hepatitis C in Liver Transplant Patients
Liver Transplantation.
15(2):216-222
[DOI] 10.1002/lt.21666.
[PMID] 19177434.
2008
Cyclosporine Helps To Achieve a Higher Svr in Patients Receiving Peg-Interferon/Ribavirin for Recurrent Hepatitis C After Liver Transplantation: Final Analysis of a Randomized-Controlled Study
Journal of Hepatology.
48
[DOI] 10.1016/S0168-8278(08)60197-X.
2008
Factors predicting survival after transjugular intrahepatic portosystemic shunt creation: 15 years’ experience from a single tertiary medical center.
Journal of vascular and interventional radiology : JVIR.
19(11):1576-81
[DOI] 10.1016/j.jvir.2008.07.021.
[PMID] 18789725.
2008
Hbv Recurrence Rate Post-Liver Transplantation (Olt) and Associated Factors: Results of the Nih-Hbv-Olt Study
Higher Education Policy.
48:571A-572A
2008
Hepatocellular Carcinoma (Hcc) Is the Main Indication for Liver Transplantation (Olt) Among Hbv Patients in the Era of Nucleos/Tide Analogue Therapies
Higher Education Policy.
48:946A-947A
2008
Hepatocellular Carcinoma Is Associated With An Impaired Cd4 T Cell Immune Response
Journal of Hepatology.
48
[DOI] 10.1016/S0168-8278(08)60360-8.
2008
Impact of Antiviral Resistance Mutations in the Hepatitis B Virus (Hbv) P Gene On Hbv S Gene and Implications for Liver Transplant (Olt) Patients
Higher Education Policy.
48:699A-700A
2008
Impact of the hepatitis B virus genotype on pre- and post-liver transplantation outcomes.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
14(10):1420-7
[DOI] 10.1002/lt.21563.
[PMID] 18825703.
2008
Recurrent Hepatocellular Carcinoma in Liver Transplant Recipients With Hepatitis C
American Journal of Transplantation.
8
2008
The Natural History of Hcv-Related Cirrhosis After Liver Transplantation
Journal of Hepatology.
48
[DOI] 10.1016/S0168-8278(08)60003-3.
2008
Using Immune Functional Assay To Differentiate Acute Cellular Rejection From Recurrent Hepatitis C in Liver Transplant Patients
Higher Education Policy.
48
2007
Listeria monocytogenes following orthotopic liver transplantation: central nervous system involvement and review of the literature.
World journal of gastroenterology.
13(32):4391-3
[PMID] 17708617.
2007
Presence of intrahepatic (total and ccc) HBV DNA is not predictive of HBV recurrence after liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
13(8):1137-44
[PMID] 17663390.
2007
Prevalence and predictors of esophageal varices in patients with primary biliary cirrhosis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
5(7):803-8
[PMID] 17544879.
2006
Betaine resolves severe alcohol-induced hepatitis and steatosis following liver transplantation.
Digestive diseases and sciences.
51(7):1226-9
[PMID] 16944015.
2006
Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
12(1):51-7
[PMID] 16382464.
2006
Impact of implementation of the MELD scoring system on the prevalence and incidence of chronic renal disease following liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
12(5):754-61
[PMID] 16528716.
2006
Late presentation of a biliary tract complication after right hepatic donation resulting in secondary biliary cirrhosis.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
12(2):306-9
[PMID] 16447188.
2006
Longterm Care of the Liver Transplant Recipient
.
2006
Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
12(1):124-33
[PMID] 16382463.
2005
Liver Re-Transplantation: A Single Center Outcome and Financial Analysis
Transplantation proceedings.
37(2):1161-1163
2005
Liver retransplantation: a single-center outcome and financial analysis.
Transplantation proceedings.
37(2):1161-3
[DOI] 10.1016/j.transproceed.2004.11.046.
[PMID] 15848656.
2005
Short recovery time after percutaneous liver biopsy: should we change our current practices?
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
3(9):926-9
[PMID] 16234032.
2004
Autonomic dysfunction and gastroparesis in cirrhosis.
Journal of clinical gastroenterology.
38(1):72-6
[PMID] 14679331.
2004
One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
10(10):1240-7
[PMID] 15376304.
2004
Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
10(2):199-207
[PMID] 14762857.
2003
Hepatitis B virus genotypes in the United States: results of a nationwide study.
Gastroenterology.
125(2):444-51
[PMID] 12891547.
2003
Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect.
Hepatology (Baltimore, Md.).
38(4):859-68
[PMID] 14512873.
2003
Prevalence of HBV precore/core promoter variants in the United States.
Hepatology (Baltimore, Md.).
38(3):619-28
[PMID] 12939588.
2002
Combination Of Interferon Alfa-2b and Ribavirin in liver transplant recipients with histologic recurrent hepatitis C
Liver Transplantation.
8(11):1000-1006
[DOI] 10.1053/jlts.2002.34968.
[PMID] 12424712.
2002
Effect Of Lamivudine Treatment On Survival Of 309 North American Patients Awaiting Liver Transplantation For Chronic Hepatitis B.
Liver Transplantation.
8(5):433-9
[PMID] 12004342.
2001
Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation.
Liver Transplantation.
7(12):1064-1070
[DOI] 10.1053/jlts.2001.29414.
[PMID] 11753908.
2001
Liver Transplantation in Patients with Hepatitis B Virus Infection: Outcome in asian versus white patients
Hepatology.
34(1):126-132
2001
Susceptibility of liver allografts to high or low concentrations of preformed antibodies as measured by flow cytometry.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
1(2):152-6
[PMID] 12099363.
1994
Clinical and endoscopic features of rejection in small bowel transplant recipients
Transplantation proceedings.
26(3):1413-1413
1994
Endoscopy is essential for early detection of rejection in small bowel transplant recipients
Transplantation proceedings.
26(3):1414-1415
1994
Epidemiology and serologic diagnosis of hepatitis E
.
20(5):567-569
1993
Pseudopolyposis medicamentosus
.
39(2):213-214
1991
Bacterial Infections in a Hematology and Oncology Inpatient Unit: Changing Spectrum of Bacteremia
Puerto Rico health sciences journal.
10(1)
Grants
Oct 2018
– Oct 2023
An Observational Study of Patients Undergoing Therapy for Chronic Hepatitis B Virus (HBV) Infection; (TARGET-HBV)
Role: Principal Investigator
Funding: TARGET PHARMASOLUTIONS dba TARGET RWE
Nov 2014
ACTIVE
214 OPERATING ACCOUNT
Role: Principal Investigator
Funding: UNIV OF FLORIDA
Jun 2014
– Sep 2018
BMS AI444-257 A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination with Sofosbuvir for the Treatment of Post-Liver Transplant Subjects with Chronic Hepatitis C
Role: Project Manager
Funding: BRISTOL MYERS SQUIBB CO
Education
Gastroenterology
1994
·
Tulane University
Tx Hepatology
1993
·
University of Pittsburgh
Gastroenterology
1992
·
SUNY Health Science Center
Residency – Internal Medicine
1989
·
Veteran Affairs Medical Center
Internship – Internal Medicine
1987
·
Veteran Affairs Medical Center
MD
1986
·
University of Puerto Rico
Bachelor in Science-Biology
1981
·
Yale
Contact Details
Phones:
- Business:
- (352) 273-9400
Emails:
- Business:
- soldevc@medicine.ufl.edu
Addresses:
- Business Mailing:
-
1329 SW 16TH ST STE 5251
GAINESVILLE FL 32608 - Business Street:
-
PO Box 100214
GAINESVILLE FL 32610